These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33559163)

  • 1. Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats.
    Jaikumkao K; Promsan S; Thongnak L; Swe MT; Tapanya M; Htun KT; Kothan S; Intachai N; Lungkaphin A
    J Cell Physiol; 2021 Sep; 236(9):6424-6440. PubMed ID: 33559163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats.
    Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak LO; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
    Diabetes Obes Metab; 2018 Nov; 20(11):2617-2626. PubMed ID: 29923295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model.
    Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak L; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats.
    Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
    Clin Sci (Lond); 2019 Dec; 133(23):2415-2430. PubMed ID: 31769484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
    Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Toxicol Appl Pharmacol; 2017 Oct; 333():43-50. PubMed ID: 28807765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways.
    Arab HH; Al-Shorbagy MY; Saad MA
    Chem Biol Interact; 2021 Feb; 335():109368. PubMed ID: 33412153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.
    Tanajak P; Sa-Nguanmoo P; Sivasinprasasn S; Thummasorn S; Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2018 Feb; 236(2):69-84. PubMed ID: 29142025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
    Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapagliflozin attenuates renal gluconeogenic enzyme expression in obese rats.
    Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
    J Endocrinol; 2020 May; 245(2):193-205. PubMed ID: 32092034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats.
    Cherngwelling R; Pengrattanachot N; Swe MT; Thongnak L; Promsan S; Phengpol N; Sutthasupha P; Lungkaphin A
    Toxicol Appl Pharmacol; 2021 Aug; 425():115601. PubMed ID: 34081941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine, a structural analog of melatonin, improves kidney dysfunction through regulating the AMPK/mTOR signaling pathway to promote autophagy in obese rats.
    Promsan S; Thongnak L; Pengrattanachot N; Phengpol N; Sutthasupha P; Lungkaphin A
    Food Chem Toxicol; 2022 Jul; 165():113190. PubMed ID: 35640855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation.
    Pengrattanachot N; Cherngwelling R; Jaikumkao K; Pongchaidecha A; Thongnak L; Swe MT; Chatsudthipong V; Lungkaphin A
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165741. PubMed ID: 32101757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
    Terami N; Ogawa D; Tachibana H; Hatanaka T; Wada J; Nakatsuka A; Eguchi J; Horiguchi CS; Nishii N; Yamada H; Takei K; Makino H
    PLoS One; 2014; 9(6):e100777. PubMed ID: 24960177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of renal inflammation and endoplasmic reticulum stress by vildagliptin and statins in high-fat high-fructose diet-induced insulin resistance and renal injury in rats.
    Thongnak L; Chatsudthipong V; Lungkaphin A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158755. PubMed ID: 32534015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance.
    Ittichaicharoen J; Apaijai N; Tanajak P; Sa-Nguanmoo P; Chattipakorn N; Chattipakorn S
    Arch Oral Biol; 2018 Jan; 85():148-153. PubMed ID: 29073562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice.
    Sun X; Han F; Lu Q; Li X; Ren D; Zhang J; Han Y; Xiang YK; Li J
    Diabetes; 2020 Jun; 69(6):1292-1305. PubMed ID: 32234722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of dapagliflozin and statins ameliorates renal injury through attenuating the activation of inflammasome-mediated autophagy in insulin-resistant rats.
    Thongnak L; Pengrattanachot N; Promsan S; Phengpol N; Sutthasupha P; Chatsudthipong V; Lungkaphin A
    J Biochem Mol Toxicol; 2022 Apr; 36(4):e22978. PubMed ID: 34939712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway.
    Luo J; Sun P; Wang Y; Chen Y; Niu Y; Ding Y; Xu N; Zhang Y; Xie W
    Eur J Pharmacol; 2021 Sep; 907():174304. PubMed ID: 34224699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapagliflozin Ameliorates Ovulation Disorders via Attenuating Activated Microglia-Mediated Hypothalamic Inflammation in HFD-Fed Mice.
    Chen X; Xiao Z; Liu Q; Luo D; Cai Y; Fan M
    Neuroendocrinology; 2024; 114(4):331-347. PubMed ID: 38147832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway.
    Meng Z; Liu X; Li T; Fang T; Cheng Y; Han L; Sun B; Chen L
    Int Immunopharmacol; 2021 May; 94():107492. PubMed ID: 33647823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.